April 16th, 2025
Coronavirus Updates - Page 4
Pfizer CEO Sells 60% of His PFE Stock after COVID-19 Vaccine Proved to Be 90% Effective
By Darya Rudz
November 11th, 2020
On the same day when Pfizer announced the results of the vaccine trial, the company’s CEO Albert Bourla sold 132,508 shares (or 62% of his stock) at the price of $41.99.
Positive COVID-19 Updates Push ‘Stay-At-Home’ Stocks in Correction
By Bhushan Akolkar
November 10th, 2020
All tech companies like Zoom Video, Amazon, Netflix, and Shopify entered major correction on Monday as Pfizer and BioNTech announced that its COVID-19 vaccine candidate has delivered a 90% efficacy rate.
Pfizer COVID-19 Vaccine Efficacy Spurs Market Surge
By Godfrey Benjamin
November 9th, 2020
Following the positive news about the Pfizer COVID-19 vaccine efficacy, the stock market has responded with big jumps.
Tyler Winklevoss: Powell’s Call for More Stimulus Is Code for Buy Bitcoin
By Godfrey Benjamin
November 6th, 2020
The major reason why the economy took a down-plunge was as a result of the COVID-19 pandemic, the move to stock up on Bitcoin as a hedge against the imminent economic crash now seems to be a smart step.
A Day Before U.S. Presidential Elections: What’s at Stake for Wall Street and Global Markets?
By Bhushan Akolkar
November 2nd, 2020
Markets remain on the edge a day before the U.S. Presidential elections. Volatility is growing as this week has some big announcements from the Federal Reserve and policymakers. The surge in COVID-19 in the U.S. and Europe puts major pressure on the markets.
AstraZeneca’s COVID-19 Trial Gets Big Push from Britain’s Health Regulators
By Bhushan Akolkar
November 2nd, 2020
The British health regulators will monitor clinical data in real-time while having an active dialogue with the drugmaker to accelerate the approval process.
U.S. Weekly Jobless Claims Drops by 40k to 751,000
By Steve Muchoki
October 29th, 2020
Although there was a notable decline in jobless claims in the United States, those people who expected to receive a stimulus payment before the elections were frustrated after the lawmakers failed to make a deal on it.
Moderna Releases Q3 Earnings as It Confirms Its Geared Up Activity to Meet Up with Its Vaccine Demand
By Godfrey Benjamin
October 29th, 2020
Massachusetts-Based biotechnology company Moderna Inc (NASDAQ: MRNA), one of the top pharmaceutical companies in search of a COVID-19 vaccine, has released its Q3 financial earnings while confirming its preparations to meet up with the expected surge in demand for its vaccine once approved.
Dow Jones Records 185 Points Decline amid U.S. COVID-19 Increased Cases
By John K. Kumi
October 26th, 2020
According to the latest analysis, major U.S. equity benchmarks Like Dow Jones recorded a decline of 180 point. This decline has been linked to the 83,000 new coronavirus cases recorded in Sun Belt State over the weekend.
Remdesivir Is Now The Official Drug for COVID-19 Treatment in The U.S.
By Godfrey Benjamin
October 23rd, 2020
Gilead Sciences Inc revealed on Thursday that the Food and Drug Administration (FDA) has given the approval to Remdesivir as the first official treatment for COVID-19 in the United States.
WHO Study Shows Remdesivir Is Not as Potent in Reducing COVID-19 Mortality Rate as Claimed
By Godfrey Benjamin
October 16th, 2020
The increasing rise in COVID-19 cases may further stir a boost in the demand for Remdesivir despite the WHO claims.
RYA Shares Drop 3% as New COVID-19 Restrictions Forces Ryanair to Cut Winter Capacity
By Godfrey Benjamin
October 15th, 2020
A new set of COVID-19 restrictions will strain Ryanair (RYA) as well as other airline companies globally.
JNJ Shares Down 2.29% Following Johnson & Johnson COVID-19 Vaccine Trial Mishap
By Godfrey Benjamin
October 14th, 2020
The adverse event which has caused a halt in the clinical trials influenced investor’s confidence yesterday as JNJ shares lost 2.29% to close at $148.36.
Major Global Markets Up on Monday as Investors Closely Monitor Trump Response to Coronavirus Treatment
By Steve Muchoki
October 5th, 2020
Analysts have agreed that the primary concern for investors at the current moment mostly revolves around whether Trump’s illness will affect a presidential race in which he continues to lag behind Democratic challenger Joe Biden.
Major Global Stock Markets Plummets after Trump and First Lady Test Positive for Coronavirus
By Steve Muchoki
October 2nd, 2020
President Trump and the First Lady tested positive for COVID-19 a few days after the first presidential debate with Democratic presidential candidate, Joe Biden.